Glenda Gray Selected Research

Glenda Gray Research Topics

Disease

29	Infections 08/2022 - 02/2003
15	HIV Infections (HIV Infection) 01/2021 - 06/2004
7	COVID-19 08/2022 - 01/2020
4	Bacterial Vaginosis 01/2020 - 07/2015
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2017 - 06/2004
2	Neutropenia 01/2021 - 06/2012
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2019 - 01/2019
2	Inflammation (Inflammations) 01/2019 - 01/2018
2	Vaccinia 01/2018 - 01/2016
2	Viremia 05/2010 - 04/2005
1	Breakthrough Infections 01/2022
1	Cross Infection (Nosocomial Infection) 01/2022
1	Substance-Related Disorders (Drug Abuse) 11/2021
1	Exanthema (Rash) 12/2020
1	Headache (Headaches) 12/2020
1	Weight Loss (Weight Reduction) 12/2020
1	Vaginal Discharge 09/2019
1	Dysbiosis 01/2019
1	Candidiasis (Moniliasis) 01/2019
1	Stillbirth 01/2018
1	Back Pain (Backache) 01/2018
1	Dizziness (Lightheadedness) 01/2018
1	Syphilis 01/2018
1	Abdominal Pain (Pain, Abdominal) 01/2018
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2017
1	Hyperglycemia 01/2017
1	Glucose Intolerance 01/2017
1	Herpes Zoster 02/2016
1	Obesity 01/2014
1	Overweight 01/2014
1	Wound Infection (Wound Infections) 10/2013
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2010
1	Amenorrhea 06/2010
1	Hemorrhage 06/2010
1	Herpes Genitalis (Genital Herpes) 01/2009

Drug/Important Bio-Agent (IBA)

17	VaccinesIBA 01/2022 - 02/2003
10	AIDS VaccinesIBA 01/2021 - 06/2004
6	Ad26COVS1IBA 08/2022 - 10/2021
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2010
4	AntigensIBA 01/2020 - 01/2014
3	Neutralizing AntibodiesIBA 01/2022 - 01/2020
3	AntibodiesIBA 11/2021 - 01/2018
3	GP 140IBA 01/2020 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2011
2	BNT162 VaccineIBA 01/2022 - 01/2022
2	Viral RNAIBA 11/2021 - 04/2009
2	RNA (Ribonucleic Acid)IBA 11/2021 - 10/2010
2	Pharmaceutical PreparationsIBA 12/2020 - 06/2012
2	Peptides (Polypeptides)IBA 01/2020 - 10/2004
2	EnzymesIBA 01/2020 - 01/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 09/2019
2	CytokinesIBA 01/2019 - 01/2019
2	16S Ribosomal RNAIBA 01/2019 - 01/2018
2	Tenofovir (Viread)FDA Link 11/2018 - 11/2018
2	Acyclovir (Aciclovir)FDA LinkGeneric 02/2016 - 01/2009
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	WastewaterIBA 11/2021
1	ElementsIBA 11/2021
1	ImmunosorbentsIBA 01/2020
1	Cefixime (Suprax)FDA Link 09/2019
1	Metronidazole (Metric)FDA LinkGeneric 09/2019
1	Doxycycline (Periostat)FDA LinkGeneric 09/2019
1	InterferonsIBA 01/2019
1	Biological FactorsIBA 01/2019
1	Coloring Agents (Dyes)IBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	InterleukinsIBA 01/2019
1	insulin receptor-related receptor (IRR)IBA 11/2018
1	Vaginal Creams, Foams, and Jellies (Vaginal Tablet)IBA 11/2018
1	AluminumIBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2018
1	Vaccine AdjuvantsIBA 01/2018
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2018
1	Broadly Neutralizing AntibodiesIBA 01/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2017
1	Adenosine Monophosphate (AMP)IBA 01/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2015
1	Floxacillin (Flucloxacillin)IBA 10/2013
1	Lamivudine (Epivir)FDA Link 06/2012
1	Zidovudine (Retrovir)FDA LinkGeneric 06/2012
1	Nevirapine (Viramune)FDA Link 06/2012
1	Nelfinavir (Viracept)FDA Link 06/2012
1	Papillomavirus Vaccines (HPV Vaccines)IBA 09/2010
1	Contraceptive Agents (Contraceptives)IBA 06/2010
1	HLA-DR Antigens (HLA-DR)IBA 05/2010
1	Biological ProductsIBA 11/2007

Therapy/Procedure

7	Therapeutics 09/2019 - 06/2006
2	Contraception (Birth Control) 01/2018 - 06/2010
1	Critical Care (Surgical Intensive Care) 01/2020
1	Highly Active Antiretroviral Therapy (HAART) 10/2018
1	Palliative Care (Palliative Therapy) 01/2018
1	Hormonal Contraception 01/2018
1	Intravenous Infusions 01/2017
1	Art Therapy 06/2012
1	Condoms (Condom) 11/2011
1	Injections 06/2010